Janssen

STELARA

View Prices
  1. Home
    2.  / 
  2. J Code
    3.  / STELARA – J3358

Manufacturer:

Janssen

Name:

STELARA

HCPCS Code Descriptor:

Ustekinumab, for intravenous injection, 1 mg

Category:

J Code

HCPCS:

J3358

NDC(s):

57894-0054-27

Primary Type:

Immunology:Anti-TNF

Generic/Specialty Status:

Single-Source

Route of Administration:

Intravenous

Potential NDC Listing Errors:

Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.

About:

STELARA is an Immunology:Anti-TNF drug manufactured by Janssen and administered via the Intravenous route of administration. The J Code: J3358 is aligned to the drug STELARA.

View Prices

Access Pricing and More By Registering

Register Now

HCPCS Added Date:

1/1/18

HCPCS Effective Date:

1/1/18

HCPCS Short Description:

Ustekinumab, iv inject, 1 mg

Billing and Coding Guide:

https://www.stelarahcp.com/sites/www.stelarahcp-v1.com.psa/files/billing-guide.pdf

Patient Assistance:

http://www.jjpaf.org/

STELARA - J3358